Is ContraFect Corp (CFRX) a Bad Choice in Biotechnology Monday?

by InvestorsObserver, Benzinga Columnist
April 10, 2023 2:11 PM | 16 seconds read |
A rating of 48 puts ContraFect Corp (CFRX) near the middle of the Biotechnology industry according to InvestorsObserver. ContraFect Corp's score of 48 means it scores higher than 48% of stocks in the industry. ContraFect Corp also received an overall rating of 46, putting it above 46% of all stocks. Biotechnology is ranked
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!